Davy James

Specialty Drugs Dominate Late-Stage Pipeline

After years of debate and regulatory hurdles, a milestone was achieved today when the FDA approved the first biosimilar in the United States. Filgrastim-sndz (Zarxio) manufactured by Sandoz, Inc, is biosimilar to Amgen Inc’s Neupogen (filgrastim), which was originally approved in 1991. Zarxio was approved for the same indications as Neupogen, for the treatment of patients receiving myelosuppressive chemotherapy; those with acute myeloid leukemia receiving induction or consolidation chemoth…

Grocery store chain joins growing list of major companies offering enhanced specialty pharmacy.

Grocery store chain joins growing list of major companies offering enhanced specialty pharmacy. Following the path previously tread by major chain grocery stores like Giant Eagle, Inc, and Hy-Vee, Inc, Wegmans Food Markets, Inc, recently announced it will enter the expanding specialty marketplace. On August 14, 2014, Wegmans said in a press release it will begin an enhanced specialty pharmacy service treating conditions in rheumatology, gastroenterology, neurology, and dermatology. With an…